microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles

被引:158
作者
Bhatt, Kirti [1 ]
Mi, Qing-Sheng [2 ,3 ]
Dong, Zheng [1 ,4 ]
机构
[1] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA
[2] Henry Ford Hlth Syst, Dept Dermatol, Detroit, MI USA
[3] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA
[4] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA
基金
美国国家卫生研究院;
关键词
Dicer; diabetic nephropathy; acute kidney injury; renal cell carcinoma; allograft rejection; RENAL-CELL CARCINOMA; INDUCED COLLAGEN EXPRESSION; GROWTH-FACTOR; CISPLATIN NEPHROTOXICITY; DIABETIC-NEPHROPATHY; MICROARRAY ANALYSIS; TARGET RECOGNITION; WILMS-TUMOR; CANCER; INJURY;
D O I
10.1152/ajprenal.00727.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Bhatt K, Mi Q, Dong Z. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 300: F602-F610, 2011. First published January 12, 2011; doi:10.1152/ajprenal.00727.2010.-MicroRNAs (miRNA) are endogenously produced, short RNAs that repress and thus regulate the expression of almost half of known protein-coding genes. miRNA-mediated gene repression is an important regulatory mechanism to modulate fundamental cellular processes such as the cell cycle, growth, proliferation, phenotype, and death, which in turn have major influences on pathophysiological outcomes. In kidneys, miRNAs are indispensable for renal development and homeostasis. Emerging evidence has further pinpointed the pathogenic roles played by miRNAs in major renal diseases, including diabetic nephropathy, acute kidney injury, renal carcinoma, polycystic kidney disease, and others. Although the field of renal miRNA research is still in its infancy and important questions remain, future investigation on miRNA regulation in kidneys has the potential to revolutionize both the diagnosis and treatment of major renal diseases.
引用
收藏
页码:F602 / F610
页数:9
相关论文
共 97 条
  • [1] The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1
    Agrawal, Raman
    Tran, Uyen
    Wessely, Oliver
    [J]. DEVELOPMENT, 2009, 136 (23): : 3927 - 3936
  • [2] MicroRNA expression profiles predictive of human renal allograft status
    Anglicheau, Dany
    Sharma, Vijay K.
    Ding, Ruchuang
    Hummel, Aurelie
    Snopkowski, Catherine
    Dadhania, Darshana
    Seshan, Surya V.
    Suthanthiran, Manikkam
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (13) : 5330 - 5335
  • [3] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [4] MicroRNAs: Novel Biomarkers for Human Cancer
    Bartels, Claudine L.
    Tsongalis, Gregory J.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (04) : 623 - 631
  • [5] Microprocessor of microRNAs: regulation and potential for therapeutic intervention
    Beezhold, Kevin J.
    Castranova, Vince
    Chen, Fei
    [J]. MOLECULAR CANCER, 2010, 9
  • [6] MicroRNA-34a Is Induced via p53 during Cisplatin Nephrotoxicity and Contributes to Cell Survival
    Bhatt, Kirti
    Zhou, Li
    Mi, Qing-Sheng
    Huang, Shuang
    She, Jin-Xiong
    Dong, Zheng
    [J]. MOLECULAR MEDICINE, 2010, 16 (9-10) : 409 - 416
  • [7] Next-generation biomarkers for detecting kidney toxicity
    Bonventre, Joseph V.
    Vaidya, Vishal S.
    Schmouder, Robert
    Feig, Peter
    Dieterle, Frank
    [J]. NATURE BIOTECHNOLOGY, 2010, 28 (05) : 436 - 440
  • [8] Chronic allograft nephropathy: What have we learned from protocol biopsies?
    Bosmans, Jean-Louis
    Ysebaert, Dirk K.
    Verpooten, Gert A.
    [J]. TRANSPLANTATION, 2008, 85 (07) : S38 - S41
  • [9] Revisiting the principles of microRNA target recognition and mode of action
    Brodersen, Peter
    Voinnet, Olivier
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2009, 10 (02) : 141 - 148
  • [10] Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3